Diana Hall

Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

Effat S. Emamian, Diana Hall, Morris J. Birnbaum et al. · Nature Genetics · 2004 · 912 citations · Full text

Psychiatry, Schizophrenia, Neuroscience +5

Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism

Lalitha Iyer, Diana Hall, Sudip Das et al. · Clinical Pharmacology & Therapeutics · 1999 · 351 citations

Sequence Variants of the Brain-Derived Neurotrophic Factor (BDNF) Gene Are Strongly Associated with Obsessive-Compulsive Disorder

Diana Hall, Alefiya Dhilla, Anna Charalambous et al. · The American Journal of Human Genetics · 2003 · 272 citations · Full text

Molecular Neuroscience, Psychiatry, Sequence Variants +11

Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene,<i>PPP3CC</i>, encoding the calcineurin gamma subunit

David J. Gerber, Diana Hall, Tsuyoshi Miyakawa et al. · Proceedings of the National Academy of Sciences · 2003 · 253 citations · Full text

Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates

Diana Hall, Gustavo Ybazeta, Giovanni Destro‐Bisol et al. · Pharmacogenetics · 1999 · 148 citations

Genetics, Human Populations, Human Polymorphism +20